Tuesday, December 05, 2023 11:14:11 AM
Jackxkr,
The problem described in this piece/video is the same one I have been complaining about since almost the beginning. It’s entrenchment of the interests behind the status quo. These folks KNOW that advancements and treatments have a great chance at being, or actually are, effective but “the process” prevents access to them by patients.
Even if what they have done turns out to be a cure, it will not be available to the masses without going through “the process” and that is what they know they are up against. Unfortunately researchers all have their own pet projects so the majority of clinicians will be held hostage by the minority of researchers tied to grant money funding for projects that show no such promise as what they see and are betting on like Ralph Steinman did, by treating one of their own.
NWBO ran this gauntlet of “the process” and only they truly have the ability to change it by exposing all the self sustaining control and push back created by various instruments of the status quo because of how well documented they are with regard to media attacks, market maker and hedge fund moves and time it took to create needed change in regulator guidance to account for new modality of treatment with immunotherapy. Even connections to legislators trying to defund endorsement of newly created rules designed to create greater accountability are being made clear. This kind of awareness is just what is needed to create change and NWBO is set to open up the whole can of worms. Nice to see the Koreans and others going deeper into allegations against the manipulators too. Best wishes.
The problem described in this piece/video is the same one I have been complaining about since almost the beginning. It’s entrenchment of the interests behind the status quo. These folks KNOW that advancements and treatments have a great chance at being, or actually are, effective but “the process” prevents access to them by patients.
Even if what they have done turns out to be a cure, it will not be available to the masses without going through “the process” and that is what they know they are up against. Unfortunately researchers all have their own pet projects so the majority of clinicians will be held hostage by the minority of researchers tied to grant money funding for projects that show no such promise as what they see and are betting on like Ralph Steinman did, by treating one of their own.
NWBO ran this gauntlet of “the process” and only they truly have the ability to change it by exposing all the self sustaining control and push back created by various instruments of the status quo because of how well documented they are with regard to media attacks, market maker and hedge fund moves and time it took to create needed change in regulator guidance to account for new modality of treatment with immunotherapy. Even connections to legislators trying to defund endorsement of newly created rules designed to create greater accountability are being made clear. This kind of awareness is just what is needed to create change and NWBO is set to open up the whole can of worms. Nice to see the Koreans and others going deeper into allegations against the manipulators too. Best wishes.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
